PPARG and diabetes mellitus: PHA stimulation of PBMCs fromhealthy donors resulted in decreased PPAR-γ expression, which was overcame by pretreatment of these cells with PPAR-γ agonist.Long-term treatment of diabetes patients with pioglitazone also overcame thedecrease in PPAR-γ expression in PHA treated PBMCs from these patients.